COVID Updates: FDA expands eligibility for remdesivir
on Friday, the agency expanded the use to include everyone who tests positive for the disease, but is not hospitalized, has mild to moderate symptoms, and is at high risk of severe illness.
on Friday, the agency expanded the use to include everyone who tests positive for the disease, but is not hospitalized, has mild to moderate symptoms, and is at high risk of severe illness.